MIPL-Logo

3decades

 

MIRA INFORM REPORT

 

 

Report No. :

516729

Report Date :

28.06.2018

 

IDENTIFICATION DETAILS

 

Name :

SAVA HEALTHCARE LIMITED (w.e.f.11.05.2015)

 

 

Formerly Known As :

ANAGHA PHARMA LIMITED (w.e.f.06.04.2015)

 

ANAGHA PHARMA PRIVATE LIMITED (w.e.f.23.12.2008)

 

ANAGHA INTERTRADE SERVICES PRIVATE LIMITED

 

 

Registered Office :

Shed No.508, GIDC 2, Wadhawan City, District Surendranagar – 363035, Gujarat

Tel. No.:

91-20-30516100

 

 

Country :

India

 

 

Financials (as on) :

31.03.2016

 

 

Date of Incorporation :

25.10.2004

 

 

CIN No.:

[Company Identification No.]

U51397GJ2004PLC074963

 

 

Capital Investment / Paid-up Capital :

INR 3.592 Million

 

 

PAN No.:

[Permanent Account No.]

AAECA9456D

 

 

GSTN :

[Goods & Service Tax Registration No.]

29AAECA9456D2ZH

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturing and Trading of wide range of Pharmaceuticals Products. [Registered Activity]

 

 

No. of Employees :

Not Divulged

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

A

 

Credit Rating

Explanation

Rating Comments

A

Acceptable Risk

Business dealings permissible with moderate risk of default

 

Maximum Credit Limit :

USD 2157000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject was incorporated in the year 2004 and it is having satisfactory track records.

 

It is engaged in the manufacturing and trading of wide range of pharmaceuticals products.

 

Management of the company has not filed its financials of 2017 with government department.

 

As per available financials of 2016, the company has increased its revenue from operations as compared to previous year and reported losses.

 

However, rating takes into consideration sound financial risk profile of the company marked by healthy networth position and low with debt balance sheet.

 

Further, rating derives strength from long standing track records of business operations along with experienced management team, established market position and reputed clientele as well as improvement in the revenue profile during the year.

 

Rating strengths are partially offset by continuously incurring losses from its business operations and intense competition from industry.

 

Trade relations are reported as fair. Business is active. Payments are slow but correct.

 

In view of the aforesaid, the company can be considered for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List

 

Country Name

Previous Rating

(31.12.2017)

Current Rating

(01.04.2018)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderately Low Risk

 

B1

Moderate Risk

 

B2

Moderately High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

SMERA

Rating

Long Term Rating = BB-

Rating Explanation

Moderate risk of default

Date

23.02.2018

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2018.

 

BIFR (Board for Industrial & Financial Reconstruction) LISTING STATUS

 

Subject’s name is not listed as a Sick Unit in the publicly available BIFR (Board for Industrial & Financial Reconstruction) list as of 28.06.2018

 

IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS

 

Subject’s name is not listed in the publicly available IBBI (Insolvency and Bankruptcy Board of India) list as of report date.

 

INFORMATION DECLINED BY

 

Name :

Mr. Nitin Utpat

Designation :

Logistics Department

Contact No.:

91-9764442274

 

Name :

Mr. Naresh

Designation :

Finance Manager

Contact No.:

91-20-30516100

Date :

23.06.2018

 

 

LOCATIONS

 

Registered Office :

Shed No.508, GIDC 2, Wadhawan City, District Surendranagar – 363035, Gujarat

Tel. No.:

91-20-30516100

Mobile No.:

91-9764442274 [Mr. Nitin Utpat]

Fax No.:

Not Available

E-Mail :

sales@savaglobal.com

anusaya.vighne@savaglobal.com

nitin.utpat@savaglobal.com

finance@savaglobal.com

Website :

http://savaglobal.com

 

 

Corporate/ Head Office :

Sava House, Off New Airport Road, Viman Nagar, Pune – 411014, Maharashtra, India

Tel. No.:

91-20-30516100

Fax No.:

91-20-30516161

 

 

Warehouse :

1st Floor, Old Property No. 1524, New 02/546, New Gat no. 1354, Wagholi, Taluka Haveli, Pune – 412207, Maharashtra, India

 

 

Branch Office:

Office #2, Lalwani Plaza, Viman Nagar,  Off New Airport Road, Sakore Nagar, Pune-411014, Maharashtra, India

 

 

DIRECTORS

 

AS ON: 31.03.2018

 

Name :

Suvarna Vinod Jadhav

Designation :

Additional Director

Address :

Plot No. 7, Windsor Estate, S.No. 17/2B, Near Bishop School, Vadgaon Sheri Pune-411014, Maharashtra, India

Date of Appointment :

28.10.2016

DIN No.:

00022798

Other Directorship :

CIN/FCRN

Company Name

Begin Date

U72900PN2008PLC156152

DEVTECH M2M LIMITED

22/12/2016

U74999PN2017PTC172053

MAXVET LIFE PRIVATE LIMITED

16/08/2017

 

 

Name :

Mr. Vishal Ramchandra Jadhav

Designation :

Director

Address :

C-1/101, Lunkad Queens Land, Viman Nagar, Pune – 411014, Maharashtra, India

Date of Birth/Age :

31.01.1977

Date of Appointment :

19.02.2013

PAN No.:

AGMPJ5005A

DIN No. :

05235986

Other Directorship :

CIN/FCRN

Company Name

Begin Date

U24231GJ1989PLC011921

SAVA HEALTHCARE LIMITED

29/09/2012

U72900GJ2009PTC074961

SAVA PRIVATE LIMITED

13/09/2013

U72900PN2008PLC156152

DEVTECH M2M LIMITED

18/10/2014

U72900PN2012PTC144479

FIRSTPAGE WEB TECHNOLOGIES PRIVATE LIMITED

16/12/2013

U74900PN2011PLC141236

SAVA BIOPHARM LIMITED

18/09/2012

U74999PN2010PLC135514

SAVA MEDICA LIMITED

29/09/2012

U74999PN2017PTC172053

MAXVET LIFE PRIVATE LIMITED

16/08/2017

 

 

Name :

Mrs. Renu Faujasingh Anjanikar

Designation :

Whole time Director

Address :

Sukhwani Pride, Flat No. 11, B Wing Morwadi, Pimpri, Pune-411018, Maharashtra, India

Date of Appointment :

19.01.2015

DIN No. :

06897268

Other Directorship :

CIN/FCRN

Company Name

Begin Date

U24231GJ1989PLC011921

SAVA HEALTHCARE LIMITED

25/06/2014

U72900PN2008PLC156152

DEVTECH M2M LIMITED

18/10/2014

U74999PN2010PLC135514

SAVA MEDICA LIMITED

30/12/2016

U74999PN2017PTC172053

MAXVET LIFE PRIVATE LIMITED

23/08/2017

 

 

Name :

Mr. Avinash Dinkar Kulkarni

Designation :

Director

Address :

Flat No-G-07, S.N-6/2/3B, Meghdoot Co-op Housing Society, Talajai Pathar, Opposite Casa 18, Dhankwadi, Pune-411043, Maharashtra, India

Date of Appointment :

24.03.2017

DIN No. :

07738165

Other Directorship :

CIN/FCRN

Company Name

Begin Date

U74999PN2010PLC135514

SAVA MEDICA LIMITED

24/03/2017

 

 

KEY EXECUTIVES

 

Name :

Anusaya Jairam Vighne

Designation :

Company Secretary

Address :

Flat No.14, B-4, Ikaar Society, Paud Road, Kothrud, Pune-411038, Maharashtra, India

Date of Appointment :

24.03.2017

PAN No.:

AIUPV3125D

 

 

Name :

Mr. Nitin Utpat

Designation :

Logistics Department

 

 

Name :

Mr. Naresh

Designation :

Finance Manager

 

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON: 31.03.2016

 

Names of Shareholders

 

No. of Shares

 

Vinod Ramchandra Jadhav

 

26671

Suvarna Jadhav

 

01

Shanta Jadhav

 

01

Vishal Jadhav

 

01

Kavya Jadhav [Through Guardian Aditi Jadhav]

 

01

Anagha Jadhav [Through Guardian Vinod Jadhav]

 

414

Amey Jadhav [Through Guardian Vinod Jadhav]

 

414

Vitra ITCL [India] Limited Trustee of winner Family Private Limited

 

8413

 

 

 

Total

 

35916

 

 

 

AS ON 12.05.2018

 

Names of Allottee

 

No. of Shares

 

Rubygold Portfolio Holdings [FZE]

 

505

 

 

 

Total

 

505

 

 

AS ON 03.04.2018

 

Names of Allottee

 

No. of Shares

 

Rubygold Portfolio Holdings [FZE]

 

251

 

 

 

Total

 

251

 

 

AS ON 08.03.2018

 

Names of Allottee

 

No. of Shares

 

Rubygold Portfolio Holdings [FZE]

 

335

 

 

 

Total

 

335

 

 

AS ON 13.02.2018

 

Names of Allottee

 

No. of Shares

 

Rubygold Portfolio Holdings [FZE]

 

246

 

 

 

Total

 

246

 

 

AS ON 20.01.2018

 

Names of Allottee

 

No. of Shares

 

Rubygold Portfolio Holdings [FZE]

 

535

 

 

 

Total

 

535

 

 

AS ON: 24.11.2016

 

Equity Share Breakup

Percentage of Holding

Category

 

Promoters – Individual/ Hindu Undivided Family – Indian

74.26

Public/Other than promoters – Individual/ Hindu Undivided Family – Indian

2.31

Public/Other than promoters - Body Corporate

23.43

 

 

Total

 

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturing and Trading of wide range of Pharmaceuticals Products. [Registered Activity]

 

 

Products :

ITC Code No.

 

Product Descriptions

99884300

Pharmaceutical product manufacturing services

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Divulged

 

 

Imports :

Not Divulged

 

 

Terms :

 

Selling :

Not Divulged

 

 

Purchasing :

Not Divulged

 

PRODUCTION STATUS: NOT AVAILABLE

 

 

GENERAL INFORMATION

 

Suppliers :

Reference:

Not Divulged

Name of the Person (Designation):

--

Contact Number:

--

Since how long known:

--

Maximum limit dealt:

--

Experience:

--

Remark

--

 

 

Customers :

 

Reference:

Not Divulged

Name of the Person (Designation):

--

Contact Number:

--

Since how long known:

--

Maximum limit dealt:

--

Experience:

--

Remark

--

 

 

No. of Employees :

Not Divulged

 

 

Bankers :

[AS ON: 31.03.2016]

·         Deutsche Bank

·         IndusInd Bank

·         Axis Bank Limited

·         UCO Bank

MID Corporate Branch, Mumbai - Pune Road, Pimpri, Pune-411018, Maharashrea, India

 

·         ICICI Bank Limited

ICICI Bank Tower, Near Chakli Circle, Old Padra Road, Vadodara-390007, Gujarat, India

 

 

Facilities :

SECURED LOANS

31.03.2016

(INR In Million)

31.03.2015

(INR In Million)

LONG-TERM BORROWINGS

 

 

Non-current maturities

 

 

Term Loan from Banks

 

 

UCO Bank

40.794

43.771

Deutsche Bank

17.920

19.039

IndusInd Bank

102.055

56.479

Term loan from others

 

 

Tata Capital Finance

0.000

27.479

Vehicle Loan from Bank

 

 

Axis Bank Limited

9.241

12.103

ICICI Bank Limited

5.704

0.000

 

 

 

SHORT TERM BORROWINGS

 

 

FCNR Loan from HDFC Bank

182.813

173.573

Cash credit - Deutsche Bank

29.440

29.802

Cash Credit – UCO Bank

19.855

18.307

 

 

 

Total

 

407.822

380.553

 

 

 

Auditors :

 

Name :

Kirtane and Pandit LLP

Chartered Accountants

Address :

5th Floor, Wing -A, Gopal House, S.No.127/1B/1, Opp. Harshal Hall, Kothrud, Pune- 411029, Maharashtra, India 

Tel. No.:

91-20-62295100/ 25433104

E-Mail :

kpca@kirtanepandit.com

PAN No.:

AAPFK1026M

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Related Party :

[AS ON: 31.03.2016]

Vitra ITCL [India] Limited Trustee of winner Family Private Limited

 

 

Subsidiary Company :

[AS ON: 31.03.2016]

·         Sava Medica Limited [U74999PN2010PLC135514]

·         Regent Holding (FZE)

 

 

Step Down Subsidiaries:

[AS ON: 31.03.2016]

·         Winner Trading FZE [Formerly known as Westside Trading Fze]

·         Regent Trading FZE [Formerly known as Rubygold Holdings Fze]

·         Sava Healthcare [Singapore Pte Limited]

·         Devtech M2M Pte Limited

·         Savesta Lifesciences Pte Limited

·         Pacific Rim International Investment Corp [Liquidated on 31st December 2015]

·         SFT Portfolio Holdings Limited [Liquidated on 31st December 2015]

·         Alps Pharma Pte Limited

·         Maplepharm Holdings Inc [Liquidated on 09th December 2015]

·         Devtech M2M FZE

·         Sava Medica Singapore Pte. Limited

·         Sava Pharma LLC

 

 

Other [or Associates]:

[AS ON: 31.03.2016]

·         Devtech M2M Limited

·         Navigene Genetic Science Private Limited [Investment sold on 22.03.2016]

 


 

CAPITAL STRUCTURE

 

AFTER: 24.11.2016

 

Authorised Capital : INR 164.000 Million

 

Issued, Subscribed & Paid-up Capital : INR 3.754 Million

 

 

AS ON: 31.03.2016

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

1140000

Equity Shares

INR 100/- each

INR 114.000 Million

5000000

Preference Shares

INR 10/- each

INR 50.000 Million

 

 

 

 

 

Total

 

INR 164.000 Million

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

35916

Equity Shares

INR 100/- each

INR 3.592 Million

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in INR Million]

 

ABRIDGED BALANCE SHEET [STANDALONE]

 

SOURCES OF FUNDS

 

31.03.2016

31.03.2015

31.03.2014

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

3.592

3.082

3.000

(b) Reserves & Surplus

751.506

652.600

559.089

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

755.098

655.682

562.089

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) Long-term borrowings

343.706

483.297

116.153

(b) Deferred tax liabilities (Net)

34.906

13.447

0.000

(c) Other long term liabilities

12.486

13.253

0.000

(d) long-term provisions

0.308

0.321

0.000

Total Non-current Liabilities (3)

391.406

510.318

116.153

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

232.108

221.682

76.709

(b) Trade payables

116.936

69.408

17.929

(c) Other current liabilities

122.389

143.307

169.357

(d) Short-term provisions

8.329

2.986

21.135

Total Current Liabilities (4)

479.762

437.383

285.130

 

 

 

 

TOTAL

1626.266

1603.383

963.372

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

585.301

569.415

32.121

(ii) Intangible Assets

102.212

109.041

0.273

(iii) Capital work-in-progress

109.416

6.069

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

97.552

103.777

429.668

(c) Deferred tax assets (net)

0.000

0.000

1.943

(d)  Long-term Loan and Advances

269.681

291.947

403.623

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

1164.162

1080.249

867.628

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

15.187

17.339

0.100

(b) Inventories

167.594

130.973

8.445

(c) Trade receivables

160.969

136.544

15.946

(d) Cash and cash equivalents

19.549

42.923

8.155

(e) Short-term loans and advances

33.664

32.017

13.150

(f) Other current assets

65.141

163.338

49.948

Total Current Assets

462.104

523.134

95.744

 

 

 

 

TOTAL

1626.266

1603.383

963.372

 

 

PROFIT & LOSS ACCOUNT [STANDALONE]

 

 

PARTICULARS

 

31.03.2016

31.03.2015

31.03.2014

 

SALES

 

 

 

 

 

Revenue from Operations

643.054

601.801

189.551

 

 

Other Income

167.142

138.972

50.649

 

 

TOTAL                                    

810.196

740.773

240.200

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials Consumed

283.809

296.478

0.000

 

 

Purchases of Stock-in-Trade

16.683

7.127

86.202

 

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

(18.409)

(1.489)

23.253

 

 

Employees benefits expense

161.456

135.203

6.098

 

 

Other expenses

218.863

155.668

21.776

 

 

R and D Expenses

15.633

40.013

0.000

 

 

TOTAL                                    

678.035

633.000

137.329

 

 

 

 

 

 

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

132.161

107.773

102.871

 

 

 

 

 

Less

FINANCIAL EXPENSES                       

40.867

37.447

11.929

 

 

 

 

 

 

PROFIT/ (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION              

91.294

70.326

90.942

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                    

75.982

65.973

5.558

 

 

 

 

 

 

PROFIT/ (LOSS) BEFORE TAX                        

15.312

4.353

85.384

 

 

 

 

 

Less

TAX                                                                 

24.360

15.423

22.792

 

 

 

 

 

 

PROFIT/ (LOSS) AFTER TAX               

(9.048)

(11.070)

62.592

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export of goods on FOB Basis 

324.365

325.698

187.569

 

 

Sale of Services

0.835

1.567

0.000

 

 

Dividend

162.399

131.440

48.080

 

TOTAL EARNINGS

487.599

458.705

235.649

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

6.837

4.783

0.000

 

 

Packaging Material

47.659

58.230

0.000

 

TOTAL IMPORTS

54.496

63.013

0.000

 

 

 

 

 

 

Earnings/ (Loss) Per Share (INR)

(252.00)

(359.00)

2086.00

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

PARTICULARS

 

31.03.2016

31.03.2015

31.03.2014

Current Maturities of Long term debt

28.540

28.125

12.088

 

 

 

 

Cash generated from operations

51.698

(883.485)

35.616

 

 

 

 

Net Cash flow from (used in) Operations

NA

NA

NA

 

 

KEY RATIOS

 

EFFICIENCY RATIOS

 

PARTICULARS

 

31.03.2016

31.03.2015

31.03.2014

Average Collection Days

(Sundry Debtors / Income * 365 Days)

91.37

82.82

30.71

 

 

 

 

Account Receivables Turnover

(Income / Sundry Debtors)

3.99

4.41

11.89

 

 

 

 

Average Payment Days

(Sundry Creditors / Purchases * 365 Days)

142.04

83.44

75.92

 

 

 

 

Inventory Turnover

(Operating Income / Inventories)

0.79

0.82

12.18

 

 

 

 

Asset Turnover

(Operating Income / Net Fixed Assets)

0.17

0.16

3.18

 

LEVERAGE RATIOS

 

PARTICULARS

 

31.03.2016

31.03.2015

31.03.2014

Debt Ratio

((Borrowing + Current Liabilities) / Total Assets)

0.52

0.59

0.43

 

 

 

 

Debt Equity Ratio

(Total Liability / Networth)

0.80

1.12

0.36

 

 

 

 

Current Liabilities to Networth

(Current Liabilities / Net Worth)

0.64

0.67

0.51

 

 

 

 

Fixed Assets to Networth

(Net Fixed Assets / Networth)

1.06

1.04

0.06

 

 

 

 

Interest Coverage Ratio

(PBIT / Financial Charges)

3.23

2.88

8.62

 

PROFITABILITY RATIOS

 

PARTICULARS

 

 

31.03.2016

31.03.2015

31.03.2014

Net Profit Margin

((PAT / Sales) * 100)

%

(1.41)

(1.84)

33.02

 

 

 

 

 

Return on Total Assets

((PAT / Total Assets) * 100)

%

(0.56)

(0.69)

6.50

 

 

 

 

 

Return on Investment (ROI)

((PAT / Networth) * 100)

%

(1.20)

(1.69)

11.14

 

SOLVENCY RATIOS

 

PARTICULARS

 

31.03.2016

31.03.2015

31.03.2014

Current Ratio

(Current Assets / Current Liabilities)

0.96

1.20

0.34

 

 

 

 

Quick Ratio

((Current Assets – Inventories) / Current Liabilities)

0.61

0.90

0.31

 

 

 

 

G-Score Ratio Financial

(Networth / Total Assets)

0.46

0.41

0.58

 

 

 

 

G-Score Ratio Debt

(Debts / Equity Capital)

168.25

237.87

68.32

 

 

 

 

G-Score Ratio Liquidity

(Total Current Assets / Total Current Liabilities)

0.96

1.20

0.34

Total Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term debts

 

 

FINANCIAL ANALYSIS

[all figures are in INR Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2014

31.03.2015

31.03.2016

 

INR In Million

INR In Million

INR In Million

Share Capital

3.000

3.082

3.592

Reserves & Surplus

559.089

652.600

751.506

Money received against share warrants

0.000

0.000

0.000

Share Application money pending allotment

0.000

0.000

0.000

Net worth

562.089

655.682

755.098

 

 

 

 

long-term borrowings

116.153

483.297

343.706

Short term borrowings

76.709

221.682

232.108

Current Maturities of Long term debt

12.088

28.125

28.540

Total borrowings

204.950

733.104

604.354

Debt/Equity ratio

0.365

1.118

0.800

 

 


 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2014

31.03.2015

31.03.2016

 

INR In Million

INR In Million

INR In Million

Sales

189.551

601.801

643.054

 

 

217.488

6.855

 

 


 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2014

31.03.2015

31.03.2016

 

INR In Million

INR In Million

INR In Million

Sales

189.551

601.801

643.054

Profit/ (Loss)

62.592

(11.070)

(9.048)

 

33.02%

(1.84%)

(1.41%)

 


ABRIDGED BALANCE SHEET [CONSOLIDATED]

 

SOURCES OF FUNDS

 

 

31.03.2016

31.03.2015

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

 

3.592

67.642

(b) Reserves & Surplus

 

1206.062

1019.663

(c) Money received against share warrants

 

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

 

0.000

0.000

Minority Interest

 

29.116

-27.572

Total Shareholders’ Funds (1) + (2)

 

1238.770

1059.733

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) Long-term borrowings

 

964.606

1517.293

(b) Deferred tax liabilities (Net)

 

0.000

16.826

(c) Other long term liabilities

 

12.486

35.274

(d) long-term provisions

 

2.063

0.321

Total Non-current Liabilities (3)

 

979.155

1569.714

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

 

232.108

221.682

(b) Trade payables

 

184.087

103.980

(c) Other current liabilities

 

113.259

33.095

(d) Short-term provisions

 

8.329

2.985

Total Current Liabilities (4)

 

537.783

361.742

 

 

 

 

TOTAL

 

2755.708

2991.189

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

608.263

582.279

(ii) Intangible Assets

 

104.782

112.896

(iii) Capital work-in-progress

 

110.453

7.106

(iv) Intangible assets under development

 

0.000

0.000

Goodwill

 

340.935

0.000

(b) Non-current Investments

 

273.551

938.843

(c) Deferred tax assets (net)

 

56.963

95.248

(d)  Long-term Loan and Advances

 

37.041

73.634

(e) Other Non-current assets

 

0.000

0.000

Total Non-Current Assets

 

1531.988

1810.006

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

15.186

17.339

(b) Inventories

 

379.659

141.425

(c) Trade receivables

 

332.307

531.695

(d) Cash and cash equivalents

 

320.163

63.898

(e) Short-term loans and advances

 

72.202

198.550

(f) Other current assets

 

104.203

228.276

Total Current Assets

 

1223.720

1181.183

 

 

 

 

TOTAL

 

2755.708

2991.189

 

 

PROFIT & LOSS ACCOUNT [CONSOLIDATED]

 

 

PARTICULARS

 

 

31.03.2016

31.03.2015

 

SALES

 

 

 

 

 

Revenue from Operations

 

2210.443

2265.987

 

 

Other Income

 

808.008

255.147

 

 

TOTAL                                    

 

3018.451

2521.134

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials Consumed

 

234.685

266.322

 

 

Purchases of Stock-in-Trade

 

669.600

741.476

 

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

 

37.530

294.337

 

 

Employees benefits expense

 

272.105

173.786

 

 

Other expenses

 

617.816

623.029

 

 

Impairment Losses

 

798.624

0.000

 

 

R and D Expenses

 

19.633

39.976

 

 

TOTAL                                    

 

2649.993

2138.926

 

 

 

 

 

 

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

 

368.458

382.208

 

 

 

 

 

Less

FINANCIAL EXPENSES                       

 

54.318

57.490

 

 

 

 

 

 

PROFIT/ (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION              

 

314.140

324.718

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                    

 

84.118

75.621

 

 

 

 

 

 

PROFIT/ (LOSS) BEFORE TAX                        

 

230.022

249.097

 

 

 

 

 

Less

TAX                                                                 

 

20.486

15.423

 

 

 

 

 

 

PROFIT/ (LOSS) AFTER TAX               

 

209.536

233.674

 

 

 

 

 

 

Earnings/ (Loss) Per Share (INR)

 

5834.00

76.00

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report

(Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

No

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

No

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

No

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

Yes

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

No

35

Negative Reporting by Auditors in the Annual Report

No

 

 

INDEX OF CHARGES

 

CHARGES REGISTERED

SNO

SRN

CHARGE ID

CHARGE HOLDER NAME

DATE OF CREATION

DATE OF MODIFICATION

DATE OF SATISFACTION

AMOUNT

ADDRESS

1

G86681053

100174526

ICICI BANK LIMITED

23/11/2017

-

-

1414000.0

ICICI BANK TOWER, NEAR CHAKLI CIRCLE,OLD PADRA ROADVADODARAGU390007IN

2

B78442209

10434194

UCO BANK

29/05/2013

-

-

110000000.0

MID CORPORATE BRANCHMUMBAI - PUNE ROAD, PIMPRIPUNEMH411018IN

3

G14906622

10434201

UCO BANK

29/05/2013

04/10/2016

-

162000000.0

1ST FLOOR, UCO BANK BIDG, H.A. COLONY, KHARALWADIPIMPRIPUNEMH411018IN

4

B67277459

10401098

STANDARD CHARTERED BANK

30/01/2013

-

-

53700000.0

B-2, CERELERUM IT PARK, KUMAR CITYVADGAON SHERI, KALYANI NAGARPUNEMH411014IN

5

C16560583

10342312

YES BANK LIMITED

09/02/2012

-

11/08/2014

10000000.0

9TH FLOOR, NEHRU CENTRE, DISCOVERY OF INDIA,DR. ANNIE BESANT ROAD, WORLI,MUMBAIMH400018IN

6

C15666118

10324379

YES BANK LIMITED

18/11/2011

05/01/2012

02/08/2014

140000000.0

9TH FLOOR, NEHRU CENTRE, DISCOVERY OF INDIA,DR. ANNIE BESANT ROAD, WORLI,MUMBAIMH400018IN

7

B68199413

10269568

KOTAK MAHINDRA BANK LIMITED

19/01/2011

15/02/2012

05/02/2013

50000000.0

36-38A, NARIMAN BHAVAN, 227,D,NARIMAN POINT,MUMBAIMH400021IN

8

B12132601

10183670

KOTAK MAHINDRA BANK LIMITED

26/09/2009

11/03/2010

09/05/2011

100000000.0

36-38A, NARIMAN BHAVAN, 227,D,NARIMAN POINT,MUMBAIMH400021IN

9

B10921039

90095431

AXIS BANK LIMITED

09/03/2005

07/07/2009

07/04/2011

38491000.0

TRISHUL 3RD FLOOR OPP SAMARTHESHWAR TEMPLELAW GARDEN ELLISBRIDGEAHMEDABADGJ380006IN

1

G86681053

100174526

ICICI BANK LIMITED

23/11/2017

-

-

1414000.0

ICICI BANK TOWER, NEAR CHAKLI CIRCLE,OLD PADRA ROADVADODARAGU390007IN

 

 

UNSECURED LOANS

 

PARTICULARS

31.03.2016

(INR In Million)

31.03.2015

(INR In Million)

LONG-TERM BORROWINGS

 

 

Loan from Directors

19.785

210.226

Others

39.007

0.000

From other than related parties

109.200

114.200

 

 

 

Total

 

167.992

324.426


CONTINGENT LIABILITIES:

 

Particulars

31.03.2016

(INR In Million)

31.03.2015

(INR In Million)

Foreign Bank Guarantees [secured by equal amount fixed deposits]

1.431

6.997

Letter of credit issued by import / Domestic of packaging material

6.976

0.000

Case filed an employee against Company

0.030

0.000

                        

 

 

Total

 

8.437

6.997

 

 

COMPANY OVERVIEW: [AS ON: 31.03.2016]

 

Sava Healthcare Limited previously known as Anagha Pharma Limited was incorporated in 2004. The registered office of the company is Surendranagar, Gujarat. The company is engaged in the business of manufacturing and trading of wide range of pharmaceuticals products.

 

 

AMALGAMATION OF SAVA HEALTHCARE LIMITED (SHL) AND SAVA PRIVATE LIMITED (SPL) WITH THE COMPANY (ANAGHA PHARMA PRIVATE LIMITED-APPL)

 

SHL and SPl ere engaged in the production of pharmaceutical drugs in the state of Gujarat and Karnataka respectively. Both SHL and SPL were subsidiaries of erstwhile Anagha Pharma Private Limited (APPL). On 6 April 2015, APPL was converted from private limited company to public company (limited by shares). Subsequently, on 11 May 2015, Anagha Pharma Limited (APL) is renamed as Sava Healthcare Limited (SHL).

 

 

AMALGAMATION SCHEME

 

The scheme of Amalgamation amongst Sava Healthcare Limited SHL), Sava Private Limited (SPL) and the company (Anagha Pharma Private limited-APPL) was sanctioned by the High court of Gujarat at Ahmedabad vide its order dated October 17, 2014. The appointed date as per the scheme is April 1, 2012. The Scheme of Amalgamation get effective on December 5, 2014 by filling of the aforesaid order with the Registrar of Companies. The above scheme have been given effect to in the financial statements for the year ended March 31, 2015.

 

FIXED ASSETS:

 

Tangible Assets

 

·         Land

·         Buildings

·         Plant and Equipment

·         Furniture and Fixtures

·         Vehicles

·         Office Equipment

·         Computer

 

 

 

 

 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

INR

US Dollar

1

INR 68.52

UK Pound

1

INR 90.60

Euro

1

INR 79.87

 

 

INFORMATION DETAILS

 

Information Gathered by :

TEJ

 

 

Analysis Done by :

PRS

 

 

Report Prepared by :

RUP

 


 

SCORE FACTORS

 

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

 

 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.